Companies which are more than 50% undervalued based on analyst price target.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
VSURE	€9.90	-12.7%	n/a	€11.0b	€16.35	2.6	61.9%	2.0%	Commercial Services
BONEX	SEK 222.40	0.6%	-30.2%	SEK 14.7b	SEK 358.25	68.5	32.8%	n/a	Pharmaceuticals & Biotech
INTRUM	SEK 3.35	4.8%	-94.0%	SEK 10.5b	SEK 20.15	0.6	100.3%	0%	Commercial Services
VIT B	SEK 235.60	-2.2%	-37.2%	SEK 9.4b	SEK 419.71	20.2	13.8%	1.6%	Software
DOM	SEK 24.74	3.9%	-51.4%	SEK 7.9b	SEK 40.00	25.6	46.4%	0%	Automobiles
KAR	SEK 70.00	-1.8%	-40.2%	SEK 6.7b	SEK 108.33	7.1	-29.0%	0%	Media
TRUE B	SEK 18.60	0.8%	-60.8%	SEK 6.1b	SEK 34.23	23.8	25.2%	1.5%	Software
RAY B	SEK 173.50	-1.6%	-43.4%	SEK 6.1b	SEK 310.00	26.5	20.3%	2.3%	Healthcare
ANOD B	SEK 40.40	0.1%	-63.1%	SEK 5.4b	SEK 74.60	16.9	16.4%	2.8%	Software
ZZ B	SEK 131.40	2.5%	-47.4%	SEK 5.0b	SEK 215.00	13.7	8.6%	4.6%	Retail
OVZON	SEK 37.20	-2.1%	-10.5%	SEK 4.3b	SEK 66.50	18.2	4.9%	n/a	Telecom
COFFEE B	SEK 17.05	-6.0%	n/a	SEK 3.9b	SEK 26.90	346.0	38.6%	4.0%	Media
SECARE	SEK 21.90	-0.9%	-40.7%	SEK 3.5b	SEK 39.50	43.7	43.5%	1.3%	Pharmaceuticals & Biotech
HNSA	SEK 34.42	-5.2%	14.6%	SEK 3.4b	SEK 73.00	18.5	40.4%	n/a	Pharmaceuticals & Biotech
BONAV B	SEK 10.30	3.5%	-9.0%	SEK 3.3b	SEK 16.25	0.5	85.9%	0%	Consumer Durables
VICO	SEK 11.18	3.3%	12.6%	SEK 3.1b	SEK 29.25	892.4	-14.8%	n/a	Pharmaceuticals & Biotech
EGTX	SEK 6.74	7.7%	18.2%	SEK 3.0b	SEK 15.33	49.7	49.8%	n/a	Pharmaceuticals & Biotech
BESQAB	SEK 29.00	0.7%	26.1%	SEK 2.9b	SEK 44.50	25.5	48.8%	n/a	Consumer Durables
AGROUP	SEK 37.20	0.5%	13.4%	SEK 2.3b	SEK 80.00	12.2	21.7%	4.2%	Real Estate Management and Development
VEFAB	SEK 1.84	5.5%	-15.4%	SEK 1.9b	SEK 3.01	6.1	-45.9%	n/a	Diversified Financials
ELAN B	SEK 54.00	8.0%	-2.5%	SEK 1.9b	SEK 89.83	27.7	47.8%	3.9%	Transportation
EG7 New	SEK 20.00	-2.0%	65.3%	SEK 1.8b	SEK 30.00	1.1	109.0%	0%	Media
SUS	SEK 35.12	3.5%	-74.6%	SEK 1.8b	SEK 60.80	34.3	28.9%	n/a	Healthcare
BINV	SEK 22.75	-1.3%	-40.4%	SEK 1.5b	SEK 95.00	6.9	43.8%	n/a	Pharmaceuticals & Biotech

Top Stock Picks from Analysts